Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
multiomics_analysis_for_dementia [2020/02/21 13:43] – [Related work] rahelehmultiomics_analysis_for_dementia [2020/04/15 18:21] – [Related work] admin
Line 45: Line 45:
   - Yamazaki, Yu., et al. "Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies." [[https://www.nature.com/articles/s41582-019-0228-7|Nat Rev Neurol ]](2019): 501–518.   - Yamazaki, Yu., et al. "Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies." [[https://www.nature.com/articles/s41582-019-0228-7|Nat Rev Neurol ]](2019): 501–518.
   - Ferreira, Daniel., et al. Biological subtypes of Alzheimer disease: A systematic review and meta-analysis [[https://n.neurology.org/content/neurology/early/2020/02/11/WNL.0000000000009058.full.pdf|Neurology]] (2020):94:1-13.   - Ferreira, Daniel., et al. Biological subtypes of Alzheimer disease: A systematic review and meta-analysis [[https://n.neurology.org/content/neurology/early/2020/02/11/WNL.0000000000009058.full.pdf|Neurology]] (2020):94:1-13.
 +  - Sey, Nancy YA, et al. A computational tool (H-MAGMA) for improved prediction of brain-disorder risk genes by incorporating brain chromatin interaction profiles. [[https://www.nature.com/articles/s41593-020-0603-0|Nature Neuroscience]], 2020.